Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanizedmonoclonal antibody that simultaneously blocks the ...

Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 . SHENZHEN, CHINA, Jan 24, 2025 - (ACN News ...

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January ...

The FDA had this to say: "Today's approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in ...

Doctors told Decode that among those most at risk of pollution-related diseases are outdoor and gig workers, particularly ...

Fifty years on from the first Arab Health conference held in Dubai, there has been a generational shift in the global ...

ShareFears have been triggered globally ever since the news of many masked patients seen attending several hospitals in China ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Inhalers for COPD provide steroids, bronchodilators, or combination drugs. The three types differ ... dates on your medication and get a new prescription if it expires. Take your medication ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...